Clinical trial
Low-Dose Pioglitazone in Patients With NASH (AIM 2)
NCT04501406
Study timeline
Study start (actual)2020-12-15Date precision: day
Registry last updated2025-04-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitus (T2DM)unresolved
Nonalcoholic Steatohepatitisunresolved
Interventions
PioglitazoneDRUG · verified · RxNorm: pioglitazone
PlaceboOTHER
Sponsors & collaborators
University of Floridalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04501406 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.